Physician profile
Gregory A Ewald
NPI 1073557401
$34,891.33
in general payments reported to CMS, 2019-2025
16 companies · $5,374 in 2025
The $5,374 reported for 2025 was more than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2020: $5,549 · 2021: $333 · 2022: $2,126 · 2023: $447 · 2024: $353 · 2025: $5,374.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,070 · Food and Beverage: $1,067 · Education: $37.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,070.00 |
| Food and Beverage | $1,066.76 |
| Education | $37.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $27,945.19 | 2019-2025 | Cardiomems, 2nd Gen Centrimag Primary Console, Thoratec Heartmate 3 Lvas Implant Kit |
| Kestra Medical Technology Services, INC. | $5,070.00 | 2025 | Assure Wcd |
| Abiomed | $872.16 | 2019-2025 | Impella |
| Medtronic Vascular, INC. | $273.56 | 2019 | |
| Cvrx, INC. | $183.01 | 2021 | |
| Novartis Pharmaceuticals Corporation | $151.17 | 2019-2022 | |
| Actelion Pharmaceuticals US, INC. | $133.07 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $118.86 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $90.62 | 2019-2025 | Jardiance |
| Medtronic, INC. | $33.90 | 2022 | |
| Pfizer INC. | $12.49 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $7.30 | 2019 |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Ewald listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.